Erectile Dysfunction:
A guide to diagnosis and management
References
1. Chew K K, Earle C M, Stuckey B G A, Jamrozik K, Keogh E J. Erectile dysfunction in general medical practice: Prevalence and clinical correlates. Int J Impot Res 2000; 12:41-45.

2. Zusman R M. Cardiovascular data on sildenafil citrate: Introduction. Am J Cardiol 1999; 83(5A):1c-2C.

3. Feldman H, Goldstein I, Hatzichristou D G, Krane R J, McKinlay J B. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urology 1994; 151(1):54-61.

4. Saenz de Tejada I, Anglin G, Knight J R, Emmick J T. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 2002; 25:2159-2164.

5. Diagnosis and management of erectile dysfunction: A guide for practice in Australia. New South Wales: Medimedia, 1998.

6. Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C,
Murino M, Thonneau P. Prevalence of erectile dysfunction
in France: Results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002; 42(4):382-389.

7. Conway A J, Handelsman D J, Lording D W, Stuckey B, Zajac J D. Use, misuse and abuse of androgens. Med J Aust 2000; 172:220-224.

8. Goldstein I, Lue T F, Padma-Nathan H, Rosen R C, Steers W D, Wicker P A. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338:1397-1404.

9. Lyseng-Williamson K A, Wagstaff A J. Management of erectile dysfunction. Disease Management and Health Outcomes 2002; 10 7:431-432.

10. Drory Y. Sexual activity and cardiovascular risk. Euro Heart J Suppl 2002; 4(Suppl H):H13-H18.

11. Hackett G I. What do patients expect from erectile dysfunction therapy? Eur Urol 2002; 18:4-11.

12. Brock G. Oral agents: First line therapy for erectile dysfunction. Eur Urol 2002; 18:12-16.

13. Emmick J T, Stuewe S R, Mitchell M. Overview of cardiovascular effects of tadalafil. Eur Heart J Suppl 2002; 4(Suppl H):H32-H37.

14. Padma-Nathan H, Hellstrom W J G, Kaiser F E, et al. On demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. Int J Impot Res 2001; 13:2-9.

15. Ormrod D, Easthope S E, Figgit D P. Vardenafil. Drugs Aging 2002; 19(3):217-227.

16. Heaton J. Key issues from the clinical trials of apomorphine SL. World J Urol 2001; 19:25-31.

17. Newsletter of European Association of Urology. Debruyne F M J, ed. Report of symposium held EAU Congress, Birmingham, UK, 23-26 Feb. Eur Urol 2002; 13(2):5.

18. Fallon B. Intracavernous injection therapy for male erectile dysfunction. Urol Clin North Am 1995; 22:833-845.